Prolactin gene expression in human growth hormone-secreting pituitary adenomas

• Published in: Journal of neurosurgery Vol. 72; no. 6; p. 879
• Main Authors: Nagaya, T, Seo, H, Kuwayama, A, Sakurai, T, Tsukamoto, N, Sugita, K, Matsui, N
• Format: Journal Article
• Language: English
• Published: United States 01.06.1990
• Subjects: Adenoma - genetics; Adenoma - secretion; Adult; Cytoplasm; Female; Gene Expression Regulation, Neoplastic; Growth Hormone - genetics; Growth Hormone - secretion; Humans; Immunohistochemistry; Male; Middle Aged; Nucleic Acid Hybridization; Pituitary Neoplasms - genetics; Pituitary Neoplasms - secretion; Prolactin - genetics; RNA, Messenger - metabolism
• ISSN: 0022-3085; 1933-0693
• DOI: 10.3171/jns.1990.72.6.0879

To elucidate the mechanism of hyperprolactinemia often observed in patients with growth hormone (GH)-secreting pituitary adenomas, the presence of immunoreactive prolactin (ir-PRL) and prolactin (PRL) messenger ribonucleic acid (mRNA) in the tumor tissue was examined by immunohistochemistry and cytoplasmic dot hybridization. Hyperprolactinemia was observed in three of 18 patients with GH-secreting adenoma. The tumor tissue was demonstrated to contain ir-PRL in nine patients and PRL mRNA in 13. The presence of ir-PRL in the tumor tissue was always associated with positive PRL mRNA, indicating production of PRL in GH-secreting tumors. Among the three patients with hyperprolactinemia, both ir-PRL and PRL mRNA was revealed in the tumor tissue of one, PRL mRNA but not ir-PRL was detected in the adenoma tissue of another, and neither PRL mRNA nor ir-PRL was found in the tumor tissue of the third. The association of hyperprolactinemia with the presence of both ir-PRL and PRL mRNA or PRL mRNA alone is indicative of PRL production and secretion. However, the absence of ir-PRL and PRL mRNA in the tumor tissue may indicate that hyperprolactinemia is caused by the suppression of PRL inhibitory factor due to hypothalamic dysfunction by the tumor mass. Thus, the study of PRL gene expression and immunohistochemistry in GH-secreting adenomas is valuable to understanding the pathophysiology of pituitary tumors.